Results 21 to 30 of about 38,144 (289)

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence [PDF]

Cochrane Database of Systematic Reviews, 2011
Maintenance treatments are effective in retaining patients in treatment and suppressing heroin use. Questions remain regarding the efficacy of additional psychosocial services.To evaluate the effectiveness of any psychosocial plus any agonist maintenance treatment versus standard agonist treatment for opiate dependenceWe searched the Cochrane Drugs and
Laura, Amato, Silvia, Minozzi, Marina, Davoli, Simona, Vecchi   +3 more
openaire   +5 more sources

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR)

BMC Nutrition, 2022
Background People with substance use disorders generally have unhealthy diets, including limited intake of fruit and vegetables. Evidence shows substantial health benefits from increasing fruit and vegetable consumption on various indicators and possibly
Lars T. Fadnes, Einar Furulund, Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Jørn Henrik Vold, Maria Olsvold, Marianne Cook Pierron, Siv-Elin Leirvåg Carlsen, Rune Blomhoff, Torgeir Gilje Lid, for the ATLAS4LAR Study Group   +10 more
doaj   +1 more source

Opioid agonist treatment for pharmaceutical opioid dependent people

Cochrane Database of Systematic Reviews, 2014
There are increasing concerns regarding pharmaceutical opioid harms including overdose and dependence, with an associated increase in treatment demand. People dependent on pharmaceutical opioids appear to differ in important ways from people who use heroin, yet most opioid agonist treatment research has been conducted in people who use heroin.To assess
Nielsen, S, Larance, B, Degenhardt, L, Gowing, L, Kehler, C, Lintzeris, N   +5 more
openaire   +3 more sources

Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial

Frontiers in Psychiatry, 2022
The increasing prevalence of illicit stimulant use among those in opioid treatment programs poses a significant risk to public health, stimulant users have the lowest rate of retention and poorest outcomes among those in addiction treatment, and current ...
Christopher S. Stauffer, Christopher S. Stauffer, Christopher S. Stauffer, Salem Samson, Alex Hickok, Alex Hickok, William F. Hoffman, William F. Hoffman, Steven L. Batki   +8 more
doaj   +1 more source

Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada

Substance Abuse Treatment, Prevention, and Policy, 2019
Objective The objective was to characterize the relationship between geography, concurrent psychiatric services, all-cause mortality, and acute health care use for individuals enrolled in Opioid Agonist Treatment, in Ontario, Canada. Methods We conducted
Kristen A. Morin, Joseph K. Eibl, Joseph M. Caswell, Graham Gauthier, Brian Rush, Christopher Mushquash, Nancy E. Lightfoot, David C. Marsh   +7 more
doaj   +1 more source

Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada.

PLoS ONE, 2020
ObjectiveThe objective of this study was to evaluate the relationship between concurrent physician-based mental health services, all-cause mortality, and acute health service use for individuals enrolled in Opioid Agonist Treatment in Ontario, Canada ...
Kristen A Morin, Joseph K Eibl, Joseph M Caswell, Brian Rush, Christopher Mushquash, Nancy E Lightfoot, David C Marsh   +6 more
doaj   +1 more source

Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province

BMC Psychiatry, 2022
Background The last decade has shown a remarkable increase in the rates of illicit opioid use in Canada and internationally, which is associated with large increases in opioid related morbidity and mortality.
Joseph Sadek, Joseph Saunders
doaj   +1 more source

BUPRENORPHINE IN OPIOID ADDICTION TEREATMENT: STUDIES WITH METHADONE COMPARISON

Psychiatry and Clinical Psychopharmacology, 2021
Methadone maintenance treatment is the most widely used pharmacological treatment approach for opioid addiction in many countries. In spite of many benefits that was gained after the usage of full agonist methadone, especially high numbers of patients ...
E.Cüneyt Evren, Defne Tamar, Bilge Babayağmur, Duran Çakmak   +3 more
doaj  

Suboxone: History, controversy, and open questions

Frontiers in Psychiatry, 2022
There are more than 200 opioid overdose deaths each day in the US. In combating this epidemic we look to available treatment tools. Here, we find only three medications approved by the Food and Drug Administration (FDA) for the treatment of opioid use ...
Andy Sivils, Paige Lyell, John Q. Wang, Xiang-Ping Chu   +3 more
doaj   +1 more source

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline [PDF]

Canadian Medical Association Journal, 2019
KEY POINTS In 2018, at least 4460 Canadians died from an opioid overdose, of which 94% were determined to be unintentional (accidental) overdoses. This represents a 9% increase in overdose deaths from 2017 and a 48% increase from 2016.[1][1] The recent emergence of street fentanyl, carfentanil ...
Nadia, Fairbairn, Josey, Ross, Michael, Trew, Karine, Meador, Jeff, Turnbull, Scott, MacDonald, Eugenia, Oviedo-Joekes, Bernard, Le Foll, Marie-Ève, Goyer, Michel, Perreault, Christy, Sutherland   +10 more
openaire   +2 more sources